Pathway from risk factors to pharmacological treatment selection in postmenopausal women Fragility fracture age ≥50 Clinical risk factors aged ≥50 - Denosumab - Document - PDFSEARCH.IO

First Page	Meta Content
	Pathway from risk factors to pharmacological treatment selection in postmenopausal women Fragility fracture age ≥50 Clinical risk factors aged ≥50 Add to Reading List Document Date: 2015-03-27 04:41:45 Open Document File Size: 35,03 KB Share Result on Facebook SocialTag Drugs Eli Lilly and Company Osteopathies Osteoporosis Zoledronic acid Strontium ranelate Denosumab Dual-energy X-ray absorptiometry Teriparatide Medicine

Pathway from risk factors to pharmacological treatment selection in postmenopausal women Fragility fracture age ≥50 Clinical risk factors aged ≥50Add to Reading List